Growth Metrics

Cytosorbents (CTSO) Gross Margin (2011 - 2026)

Cytosorbents posted quarterly Gross Margin of 69.16% for Q1 2026, down 197.0% year-on-year from 71.29% in Q1 2025, and down 6.15% on a QoQ basis from 73.68% in Q4 2025.

Cytosorbents (CTSO) has 16 years of Gross Margin data on file, last reported at 69.16% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 197.0% year-over-year to 69.16%; the trailing twelve-month figure through Mar 2026 stood at 71.01% (up 245.0% YoY), and the FY2025 full-year result was 71.48%, up 156.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 69.16%, down from 73.68% in the prior quarter.
  • Across five years, Gross Margin topped out at 76.46% in Q1 2024 and bottomed at 44.6% in Q3 2022.
  • The 5-year median for Gross Margin is 68.35% (2024), against an average of 65.82%.
  • The widest annual swing landed in 2022, when Gross Margin slumped 3017 bps; it then surged 1904 bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 61.31% in 2022, then slipped by 0 bps to 61.27% in 2023, then rose by 12 bps to 68.35% in 2024, then gained by 8 bps to 73.68% in 2025, then decreased by 6 bps to 69.16% in 2026.
  • The last three Gross Margin figures came in at 69.16% (Q1 2026), 73.68% (Q4 2025), and 70.28% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 56.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 63.29%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 63.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 38.53%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 43.89%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 69.16%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69.16%
Dec 31, 2025 73.68%
Sep 30, 2025 70.28%
Jun 30, 2025 70.85%
Mar 31, 2025 71.12%
Dec 31, 2024 68.35%
Sep 30, 2024 61.02%
Jun 30, 2024 73.55%
Mar 31, 2024 76.46%
Dec 31, 2023 61.27%
Sep 30, 2023 63.64%
Jun 30, 2023 63.89%
Mar 31, 2023 57.73%
Dec 31, 2022 61.31%
Sep 30, 2022 44.60%
Jun 30, 2022 58.21%
Mar 31, 2022 73.79%
Dec 31, 2021 71.04%
Sep 30, 2021 74.77%
Jun 30, 2021 77.46%
Mar 31, 2021 74.04%
Dec 31, 2020 78.86%
Sep 30, 2020 72.59%
Jun 30, 2020 66.82%
Mar 31, 2020 72.61%
Dec 31, 2019 71.81%
Sep 30, 2019 72.17%
Jun 30, 2019 70.57%
Mar 31, 2019 66.51%
Dec 31, 2018 65.74%
Sep 30, 2018 64.26%
Jun 30, 2018 68.97%
Mar 31, 2018 68.17%
Dec 31, 2017 72.78%
Sep 30, 2017 60.34%
Jun 30, 2017 58.44%
Mar 31, 2017 59.71%
Dec 31, 2016 57.94%
Sep 30, 2016 60.03%
Jun 30, 2016 60.71%
Mar 31, 2016 54.73%
Dec 31, 2015 54.35%
Sep 30, 2015 52.45%
Jun 30, 2015 51.72%
Mar 31, 2015 57.89%
Dec 31, 2014 62.31%
Sep 30, 2014 59.06%
Jun 30, 2014 34.99%
Mar 31, 2014 37.62%
Dec 31, 2013 2.16%
Sep 30, 2013 38.41%
Jun 30, 2013 71.84%
Mar 31, 2013 66.91%
Dec 31, 2012 620.88%
Sep 30, 2012 3,388.38%
Jun 30, 2012 145.92%
Mar 31, 2012 -7.20%
Dec 31, 2011 67.40%